| |
Remark |
 G Protein-coupled receptors
|
|
|
Cytokine receptors
|
|
|
Nuclear receptors
|
|
|
Ion channels
|
|
|
 Transporters
|
ABC transporters
|
Solute carrier family
|
SLC5
|
SLC6
|
SLC6A1 (GABA transporter 1) [HSA:6529] [KO:K05034]
|
SLC6A2 (noradrenalin transporter) [HSA:6530] [KO:K05035]
|
Mazindol [ATC:A08AA05]
|
Sibutramine [ATC: A08AA10]
|
 D08513 Sibutramine (INN)
D02571 Sibutramine hydrochloride hydrate (JAN); Sibutramine hydrochloride (USAN)
|
Inhibitor
Inhibitor
|
Cocaine [ATC:N01BC01 R02AD03 S01HA01 S02DA02]
|
Desipramine [ATC:N06AA01]
|
Imipramine [ATC:N06AA02]
|
Clomipramine [ATC:N06AA04]
|
Trimipramine [ATC:N06AA06]
|
Lofepramine [ATC:N06AA07]
|
Amitriptyline [ATC:N06AA09]
|
Nortriptyline [ATC:N06AA10]
|
Amoxapine [ATC:N06AA17]
|
Maprotiline [ATC:N06AA21]
|
Nomifensine [ATC:N06AX04]
|
Viloxazine [ATC:N06AX09]
|
Venlafaxine [ATC:N06AX16]
|
Milnacipran [ATC:N06AX17]
|
Reboxetine [ATC:N06AX18]
|
Duloxetine [ATC:N06AX21]
|
Desvenlafaxine [ATC:N06AX23]
|
Amfetamine [ATC:N06BA01]
|
Dexamfetamine [ATC:N06BA02]
|
Metamfetamine [ATC:N06BA03]
|
Atomoxetine [ATC:N06BA09]
|
Lisdexamfetamine [ATC:N06BA12]
|
Amitifadine
|
Amitriptylinoxide
|
Edivoxetine
|
Esreboxetine
|
Imipraminoxid
|
Levomilnacipran
|
Nisoxetine
|
Pyrovalerone
|
SLC6A3 (dopamine transporter) [HSA:6531] [KO:K05036]
|
Dexfenfluramine [ATC:A08AA04]
|
Mazindol [ATC:A08AA05]
|
Sibutramine [ATC:A08AA10]
|
D08513 Sibutramine (INN)
D02571 Sibutramine hydrochloride hydrate (JAN); Sibutramine hydrochloride (USAN)
|
Inhibitor
Inhibitor
|
Cocaine [ATC:R02AD03]
|
Amfetamine [ATC:N06BA01]
|
Dexamfetamine [ATC:N06BA02]
|
Metamfetamine [ATC:N06BA03]
|
Lisdexamfetamine [ATC:N06BA12]
|
Amfonelic acid
|
Amitifadine
|
Bicifadine
|
Ioflupane I 123
|
Pyrovalerone
|
SLC6A4 (serotonin transporter) [HSA:6532] [KO:K05037]
|
Mazindol [ATC:A08AA05]
|
Sibutramine [ATC:A08AA10]
|
D08513 Sibutramine (INN)
D02571 Sibutramine hydrochloride hydrate (JAN); Sibutramine hydrochloride (USAN)
|
Inhibitor
Inhibitor
|
Dapoxetine [ATC:G04BX14]
|
Trazodone [ATC:N06AX05]
|
Cocaine [ATC:N01BC01 R02AD03 S01HA01 S02DA02]
|
Desipramine [ATC:N06AA01]
|
Imipramine [ATC:N06AA02]
|
Clomipramine [ATC:N06AA04]
|
Lofepramine [ATC:N06AA07]
|
Amitriptyline [ATC:N06AA09]
|
Nortriptyline [ATC:N06AA10]
|
Dosulepin [ATC:N06AA16]
|
Fluoxetine [ATC:N06AB03]
|
Citalopram [ATC:N06AB04]
|
Paroxetine [ATC:N06AB05]
|
Sertraline [ATC:N06AB06]
|
Fluvoxamine [ATC:N06AB08]
|
Escitalopram [ATC:N06AB10]
|
Trazodone [ATC:N06AX05]
|
Viloxazine [ATC:N06AX09]
|
Venlafaxine [ATC:N06AX16]
|
Milnacipran [ATC:N06AX17]
|
Duloxetine [ATC:N06AX21]
|
Desvenlafaxine [ATC:N06AX23]
|
Vilazodone [ATC:N06AX24]
|
Amitifadine
|
Amitriptylinoxide
|
Bicifadine
|
Levomilnacipran
|
SLC6A9 (glycine transporter type 1) (GlyT1) [HSA:6536] [KO:K05038]
|
SLC9
|
SLC12
|
SLC22
|
SLC29
|
Major facilitator superfamily
|
Others
|
|
|
Enzymes
|
|
|
Protein kinases
|
|
|
Cytokines
|
|
|
Others
|
Target-based Classification of Drugs